Page last updated: 2024-08-21

fluorobenzenes and Renal Insufficiency

fluorobenzenes has been researched along with Renal Insufficiency in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (42.86)	29.6817
2010's	4 (57.14)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Albertson, TE; Bernard, GR; Brower, RG; deBoisblanc, BP; Douglas, IS; Hite, RD; Hough, CL; Liu, KD; Matthay, MA; Rock, P; Shanholtz, C; Steingrub, J; Thompson, BT; Truwit, JD	1
Burger, DM; de Kanter, CT; Keuter, M; Koopmans, PP; van der Lee, MJ	1
Anzalone, D; Cain, VA; Cressman, MD; Shepherd, J; Stein, EA; Vidt, DG	1
Chen, PZ; Feng, Y; Kang, L; Liu, M; Liu, YZ; Wang, ZF; Zhang, YM; Zheng, JH	1
Ault, A	1
Wolfe, SM	1
Alsheikh-Ali, AA; Ambrose, MS; Karas, RH; Kuvin, JT	1

Reviews

1 review(s) available for fluorobenzenes and Renal Insufficiency

Article	Year
Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program. Atherosclerosis, 2012, Volume: 221, Issue:2 Topics: Aged; Aged, 80 and over; Biomarkers; Cholesterol, LDL; Clinical Trials as Topic; Evidence-Based Medicine; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Kidney; Male; Middle Aged; Proportional Hazards Models; Pyrimidines; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Time Factors	2012

Article

Year

Renal safety of intensive cholesterol-lowering treatment with rosuvastatin: a retrospective analysis of renal adverse events among 40,600 participants in the rosuvastatin clinical development program.

Atherosclerosis, 2012, Volume: 221, Issue:2

Topics: Aged; Aged, 80 and over; Biomarkers; Cholesterol, LDL; Clinical Trials as Topic; Evidence-Based Medicine; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Kidney; Male; Middle Aged; Proportional Hazards Models; Pyrimidines; Renal Insufficiency; Retrospective Studies; Risk Assessment; Risk Factors; Rosuvastatin Calcium; Sulfonamides; Time Factors

2012

Trials

1 trial(s) available for fluorobenzenes and Renal Insufficiency

Article	Year
Rosuvastatin for sepsis-associated acute respiratory distress syndrome. The New England journal of medicine, 2014, Jun-05, Volume: 370, Issue:23 Topics: Adult; Aged; Creatine Kinase; Double-Blind Method; Female; Fluorobenzenes; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Failure; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Respiratory Distress Syndrome; Rosuvastatin Calcium; Sepsis; Sulfonamides; Survival Analysis; Treatment Failure	2014

Article

Year

Rosuvastatin for sepsis-associated acute respiratory distress syndrome.

The New England journal of medicine, 2014, Jun-05, Volume: 370, Issue:23

Topics: Adult; Aged; Creatine Kinase; Double-Blind Method; Female; Fluorobenzenes; Hospital Mortality; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Liver Failure; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Respiratory Distress Syndrome; Rosuvastatin Calcium; Sepsis; Sulfonamides; Survival Analysis; Treatment Failure

2014

Other Studies

5 other study(ies) available for fluorobenzenes and Renal Insufficiency

Article	Year
Rhabdomyolysis in an HIV-infected patient with impaired renal function concomitantly treated with rosuvastatin and lopinavir/ritonavir. Antiviral therapy, 2011, Volume: 16, Issue:3 Topics: Anti-HIV Agents; Drug Therapy, Combination; Dyslipidemias; Fluorobenzenes; HIV Infections; HIV-1; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lopinavir; Male; Middle Aged; Pyrimidines; Pyrimidinones; Renal Insufficiency; Rhabdomyolysis; Ritonavir; Rosuvastatin Calcium; Sulfonamides; Treatment Outcome	2011
Protective effects of rosuvastatin in experimental renal failure rats via improved endothelial function. Biological research for nursing, 2013, Volume: 15, Issue:3 Topics: Animals; Fluorobenzenes; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Pyrimidines; Rats; Rats, Inbred F344; Real-Time Polymerase Chain Reaction; Renal Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; Rosuvastatin Calcium; Sulfonamides	2013
Pressure group urges rosuvastatin recall. Lancet (London, England), 2004, Mar-13, Volume: 363, Issue:9412 Topics: Adult; Advisory Committees; Drug and Narcotic Control; Female; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Middle Aged; Pyrimidines; Renal Insufficiency; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides; United States; United States Food and Drug Administration	2004
Dangers of rosuvastatin identified before and after FDA approval. Lancet (London, England), 2004, Jun-26, Volume: 363, Issue:9427 Topics: Drug Approval; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Muscular Diseases; Pyrimidines; Renal Insufficiency; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides; United States; United States Food and Drug Administration	2004
The safety of rosuvastatin as used in common clinical practice: a postmarketing analysis. Circulation, 2005, Jun-14, Volume: 111, Issue:23 Topics: Consumer Product Safety; Drug Evaluation; Drug Prescriptions; Fluorobenzenes; Humans; Kidney Diseases; Morbidity; Product Surveillance, Postmarketing; Proteinuria; Pyridines; Pyrimidines; Renal Insufficiency; Retrospective Studies; Rhabdomyolysis; Rosuvastatin Calcium; Sulfonamides	2005